Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

NYSE secures SEC approval of direct listing rule changes

Davis Polk successfully represented the New York Stock Exchange LLC (“NYSE”) before the Securities and Exchange Commission (the “SEC” or “Commission”) in connection with NYSE’s proposed…

SkyBridge Capital launch of its first bitcoin fund

Davis Polk advised SkyBridge Capital on the structuring, launch and related matters for SkyBridge Bitcoin Fund L.P., an institutional-grade private fund designed to provide investors…

Gamida Cell $75 million follow-on offering

Davis Polk advised the representatives of the underwriters in connection with the $75 million SEC-registered follow-on offering of 9,343,750 ordinary shares of Gamida Cell Ltd, which…

ImmunityBio merger with NantKwest

Davis Polk is advising Goldman Sachs & Co. LLC and Lazard Frères & Co. LLC as financial advisers to ImmunityBio, Inc. in connection with its 100% stock-for-stock merger with…

NCL $850 million senior unsecured notes offering

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by NCL Corporation Ltd. of $850 million aggregate principal amount…
Back to top